Advertisement

Topic - Janet Woodcock

Related Stories

In this March 2, 2021, photo, pharmacy technician Hollie Maloney loads a syringe with Pfizer's COVID-19 vaccine at the Portland Expo in Portland, Maine. The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, Aug. 23, 2021. (AP Photo/Robert F. Bukaty) **FILE**

FDA fully approves Pfizer-BioNTech COVID-19 shot; major step should spur vaccinations, mandates

By Tom Howell Jr. - The Washington Times

FILE - This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administration called for a government investigation into highly unusual contacts between some of her agency's drug reviewers and the maker of the controversial new Alzheimer's drug. (Biogen via AP, File)

FDA head calls for inquiry into Alzheimer’s drug review

By Matthew Perrone - Associated Press

This photo provided by Eli Lilly shows the drug Bamlanivimab. On Monday, Nov. 9, 2020, the Food and Drug Administration cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. (Courtesy of Eli Lilly via AP)

COVID-19 antibody treatment heading to states immediately: HHS

By Tom Howell Jr. - The Washington Times